Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

6.85
Delayed Data
As of Jul 20
 +0.05 / +0.74%
Today’s Change
5.20
Today|||52-Week Range
9.32
+4.58%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close6.80
Today’s open6.90
Day’s range6.85 - 6.90
Volume5,272
Average volume (3 months)11,768
Market cap$156.5M
Dividend yield--
Data as of 07/20/2017

Growth & Valuation

Earnings growth (last year)-143.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)-5.35%
P/E ratio--
Price/Sales3.12
Price/Book1.15

Competitors

 Today’s
change
Today’s
% change
KDMNKadmon Holdings Inc+0.08+2.74%
ASTAsterias Biotherapeu...+0.11+3.34%
XBITXBiotech Inc-0.40-7.74%
GNCAGenocea Biosciences ...-0.02-0.40%
Data as of 07/20/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.05
Annual revenue (last year)$47.7M
Annual profit (last year)-$2.9M
Net profit margin-6.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Erez Israeli
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts